{
    "root": "2f8bb80d-7a89-cd4d-e063-6294a90a4d87",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Memantine Hydrochloride",
    "value": "20250304",
    "ingredients": [
        {
            "name": "SUCRALOSE",
            "code": "96K6UQ3ZD4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32159"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "SODIUM CITRATE",
            "code": "1Q73Q2JULR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53258"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "MEMANTINE HYDROCHLORIDE",
            "code": "JY0WD0UA60",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64323"
        }
    ],
    "indications": {
        "text": "memantine hydrochloride oral solution indicated treatment moderate severe dementia alzheimer \u2019 type .",
        "doid_entities": [
            {
                "text": "dementia (DOID:1307)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1307"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended starting dose memantine hydrochloride 5 mg ( 2.5 ml ) daily . dose increased 5 mg increments 10 mg/day ( 2.5 ml twice daily ) , 15 mg/day ( 2.5 ml 5 ml separate doses ) , 20 mg/day ( 5 ml twice daily ) . minimum recommended interval dose increases one week . shown effective controlled trials 20 mg/day ( 5 ml twice daily ) . dosing titration schedule total daily dose strength per dose ( mg ) starting dose 5mg 5mg dose week 1 10mg 5mg ( first daily dose ) 5mg ( second daily dose ) dose week 2 15mg 5mg ( first daily dose ) 10mg ( second daily dose ) dose week 3 20mg 10mg ( first daily dose ) 10mg ( second daily dose ) memantine hydrochloride taken without food . patient misses single dose memantine hydrochloride , patient double next dose . next dose taken scheduled . patient fails take memantine hydrochloride several days , dosing may need resumed lower doses retitrated described . mix memantine hydrochloride oral solution liquid . memantine hydrochloride administered syringe . syringe used withdraw correct volume oral solution oral solution slowly squirted corner patient \u2019 mouth . special renal impairment target dose 5 mg ( 2.5 ml ) twice daily recommended patients severe renal impairment ( creatinine clearance 5 \u2013 29 ml/min based cockcroft-gault equation ) . hepatic impairment memantine hydrochloride administered caution patients severe hepatic impairment [ pharmacology ( 12.3 ) ] .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe renal impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            },
            {
                "disease": "severe hepatic impairment",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_447788"
            }
        ]
    },
    "warningsAndPrecautions": "2 mg/ml oral solution clear , colorless liquid peppermint flavor . 240 ml bottle - ndc 62135-943-37 unit dose cup 5 ml - ndc 62135-943-05 20 unit dose cups 5 ml - ndc 62135-943-24 store memantine hydrochloride oral solution 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15 30\u00b0c ( 59 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "memantine hydrochloride contraindicated patients known hypersensitivity memantine hydrochloride excipients used formulation .",
    "indications_original": "Memantine Hydrochloride Oral Solution is indicated for the treatment of moderate to severe dementia of the Alzheimer\u2019s type.",
    "contraindications_original": "The recommended starting dose of memantine hydrochloride is 5 mg (2.5 mL) once daily. The dose should be increased in 5 mg increments to 10 mg/day (2.5 mL twice daily), 15 mg/day (2.5 mL and 5 mL as separate doses), and 20 mg/day (5 mL twice daily). The minimum recommended interval between dose increases is one week. The dosage shown to be effective in controlled clinical trials is 20 mg/day (5 mL twice daily).\n                  \n                     Dosing Titration Schedule\n                  \n                  \n                     \n                        \n                           \n                              \n                           \n                           \n                              Total daily dose\n                           \n                           \n                              Strength per dose (mg)\n                           \n                        \n                        \n                           \n                              Starting Dose\n                           \n                           \n                              5mg\n                           \n                           \n                              5mg\n                           \n                        \n                        \n                           \n                              Dose after week 1\n                           \n                           \n                              10mg\n                           \n                           \n                              5mg (first daily dose)\n                           \n                        \n                        \n                           \n                              5mg (second daily dose)\n                           \n                        \n                        \n                           \n                              Dose after week 2\n                           \n                           \n                              15mg\n                           \n                           \n                              5mg (first daily dose)\n                           \n                        \n                        \n                           \n                              10mg (second daily dose)\n                           \n                        \n                        \n                           \n                              Dose after week 3\n                           \n                           \n                              20mg\n                           \n                           \n                              10mg (first daily dose)\n                           \n                        \n                        \n                           \n                              10mg (second daily dose)\n                           \n                        \n                     \n                  \n                  Memantine hydrochloride can be taken with or without food. If a patient misses a single dose of memantine hydrochloride, that patient should not double up on the next dose. The next dose should be taken as scheduled.\n                  If a patient fails to take memantine hydrochloride for several days, dosing may need to be resumed at lower doses and retitrated as described above.\n                  Do not mix memantine hydrochloride oral solution with any other liquid. Memantine hydrochloride is administered with a syringe. A syringe should be used to withdraw the correct volume of oral solution and the oral solution should be slowly squirted into the corner of the patient\u2019s mouth.\n                  Special Populations\n                  \n                     Renal Impairment\n                  \n                  A target dose of 5 mg (2.5 mL) twice daily is recommended in patients with severe renal impairment (creatinine clearance of 5 \u2013 29 mL/min based on the Cockcroft-Gault equation).\n                  \n                     Hepatic Impairment\n                  \n                  Memantine hydrochloride should be administered with caution to patients with severe hepatic impairment\n \n  [see Clinical Pharmacology (\n                     \n                        12.3\n                     \n                     )].",
    "warningsAndPrecautions_original": "2 mg/mL Oral Solution is a clear, colorless liquid with peppermint flavor.\n                  240 mL bottle - NDC 62135-943-37\n                  Unit Dose Cup 5 mL - NDC 62135-943-05\n                  20 Unit Dose Cups of 5 mL each - NDC 62135-943-24\n                  \n                     Store memantine hydrochloride oral solution at 25\u00b0C (77\u00b0F); excursions permitted to 15 to 30\u00b0C (59 to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Memantine hydrochloride is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation.",
    "drug": [
        {
            "name": "Memantine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_64323"
        }
    ]
}